• Something wrong with this record ?

The effect of different molecular weight hyaluronan on macrophage physiology

D. Krejcova, M. Pekarova, B. Safrankova, L. Kubala

. 2009 ; 30 Suppl 1 () : 106-111.

Language English Country Sweden

Document type Journal Article, Research Support, Non-U.S. Gov't

OBJECTIVES: Hyaluronan, a linear glycosaminoglycan, is an abundant component of extracellular matrix. In its native form, the high-molar-mass hyaluronan polymers have an array of structural and regulatory, mainly anti-inflammatory and anti-angiogenic, functions. In contradiction, the biological effects of fragmented low molecular weight hyaluronan are suggested to be pro-angiogenic and pro-inflammatory. METHODS: The effects of highly purified pharmacological grade hyaluronan of defined molecular weights 11, 52, 87, 250 and 970 kilodaltons were tested on mouse macrophage cell lines RAW 264.7 and MHS. The surface expression of CD44 and Toll-like receptor 2, surface receptors for hyaluronan, was determined by flow cytometry. Activation of macrophages was determined based on nitric oxide and tumour necrosis factor alpha production, inducible nitric oxide synthase expression, and the activation of the nuclear factor kappa B transcriptional factor. RESULTS: Both macrophage cell lines expressed CD44 and Toll-like receptor 2, which were significantly increased by the pre-treatment of macrophages with bacterial lipopolysaccharide. Hyaluronan of any molecular weight did not activate production of nitric oxide or tumour necrosis factor alpha in any mouse macrophage cell lines. Correspondingly, hyaluronan of any tested molecular weight did not stimulate nuclear factor kappa B activation. Similarly, hyaluronan of any molecular weight neither exerted stimulatory nor inhibitory effects on macrophages pre-treated by lipopolysaccharide. CONCLUSION: Interestingly, the data does not support the current view of low molecular weight hyaluronan as a pro-inflammatory mediator for macrophages. Further studies are necessary to clarify the effects of different molecular weight hyaluronan on phagocytes.

000      
00000naa a2200000 a 4500
001      
bmc12025386
003      
CZ-PrNML
005      
20130128214420.0
007      
ta
008      
120816s2009 sw f 000 0#eng||
009      
AR
035    __
$a (PubMed)20027154
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a sw
100    1_
$a Viačková, Daniela, $d 1981- $7 _AN067095 $u Academy of Sciences of the Czech Republic, Brno, Czech Republic.
245    14
$a The effect of different molecular weight hyaluronan on macrophage physiology / $c D. Krejcova, M. Pekarova, B. Safrankova, L. Kubala
520    9_
$a OBJECTIVES: Hyaluronan, a linear glycosaminoglycan, is an abundant component of extracellular matrix. In its native form, the high-molar-mass hyaluronan polymers have an array of structural and regulatory, mainly anti-inflammatory and anti-angiogenic, functions. In contradiction, the biological effects of fragmented low molecular weight hyaluronan are suggested to be pro-angiogenic and pro-inflammatory. METHODS: The effects of highly purified pharmacological grade hyaluronan of defined molecular weights 11, 52, 87, 250 and 970 kilodaltons were tested on mouse macrophage cell lines RAW 264.7 and MHS. The surface expression of CD44 and Toll-like receptor 2, surface receptors for hyaluronan, was determined by flow cytometry. Activation of macrophages was determined based on nitric oxide and tumour necrosis factor alpha production, inducible nitric oxide synthase expression, and the activation of the nuclear factor kappa B transcriptional factor. RESULTS: Both macrophage cell lines expressed CD44 and Toll-like receptor 2, which were significantly increased by the pre-treatment of macrophages with bacterial lipopolysaccharide. Hyaluronan of any molecular weight did not activate production of nitric oxide or tumour necrosis factor alpha in any mouse macrophage cell lines. Correspondingly, hyaluronan of any tested molecular weight did not stimulate nuclear factor kappa B activation. Similarly, hyaluronan of any molecular weight neither exerted stimulatory nor inhibitory effects on macrophages pre-treated by lipopolysaccharide. CONCLUSION: Interestingly, the data does not support the current view of low molecular weight hyaluronan as a pro-inflammatory mediator for macrophages. Further studies are necessary to clarify the effects of different molecular weight hyaluronan on phagocytes.
650    _2
$a zvířata $7 D000818
650    _2
$a antigeny CD44 $x metabolismus $7 D018960
650    _2
$a buněčné linie $7 D002460
650    _2
$a průtoková cytometrie $7 D005434
650    _2
$a kyselina hyaluronová $x chemie $x metabolismus $x farmakologie $7 D006820
650    _2
$a lipopolysacharidy $x toxicita $7 D008070
650    _2
$a aktivace makrofágů $x účinky léků $x fyziologie $7 D008262
650    _2
$a makrofágy $x chemie $x účinky léků $x fyziologie $7 D008264
650    _2
$a myši $7 D051379
650    _2
$a molekulová hmotnost $7 D008970
650    _2
$a NF-kappa B $x metabolismus $7 D016328
650    _2
$a oxid dusnatý $x metabolismus $7 D009569
650    _2
$a synthasa oxidu dusnatého, typ II $x metabolismus $7 D052247
650    _2
$a toll-like receptor 2 $x metabolismus $7 D051195
650    _2
$a TNF-alfa $x metabolismus $7 D014409
655    _2
$a časopisecké články $7 D016428
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Pekarová, Michaela, $d 1982-2019 $7 mub2011659519
700    1_
$a Šafránková, Barbora
700    1_
$a Kubala, Lukáš, $d 1973- $7 xx0094314
773    0_
$w MED00168352 $t Neuro endocrinology letters $x 0172-780X $g Roč. 30 Suppl 1(2009), s. 106-111
856    41
$u https://pubmed.ncbi.nlm.nih.gov/20027154 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y m
990    __
$a 20120816 $b ABA008
991    __
$a 20130128214604 $b ABA008
999    __
$a ok $b bmc $g 947428 $s 782732
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2009 $b 30 Suppl 1 $d 106-111 $i 0172-780X $m Neuro-endocrinology letters $n Neuro-endocrinol. lett. $x MED00168352
LZP    __
$a Pubmed-20120816/10/02

Find record

Citation metrics

Loading data ...

Archiving options

Loading data ...